Literature DB >> 15859635

Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing?

Alberto Quaglia1, Nazanin Etessami, Rosalind Sim, John Difford, A P Dhillon.   

Abstract

CONTEXT: Vascular invasion is an important diagnostic and prognostic feature of hepatocellular carcinoma (HCC) in cirrhosis. Intravascular free-floating tumor clusters (IvCs) of HCC are found histologically in the vicinity of HCC. Thrombus formation is not seen morphologically in association with these IvCs, which are usually covered by endothelium.
OBJECTIVE: Our hypothesis is that these IvCs are the result of a nondestructive form of vascular invasion by HCC, and we tried to define this aspect of microvascular invasion more accurately.
DESIGN: Tissue sections were stained with hematoxylin-eosin, and consecutive sections were stained for fibrin (Martius scarlet blue, fibrinogen), platelets (factor XIIIa), smooth muscle actin, and endothelium (CD34). We studied cirrhotic livers removed at transplantation between 1997 and 1999. Of the livers studied, 35 of 81 consecutive cirrhotic livers contained HCC, and 17 showed microscopic vascular invasion. Five of these 17 cases showed IvCs and were subjected to the study. MAIN OUTCOME MEASURE: Presence or absence of thrombus formation in association with IvC.
RESULTS: Usually, IvCs were covered by endothelium, and no associated thrombus formation was seen. In 1 case of HCC, thrombus formation was seen focally in association with disruption of the endothelial coating.
CONCLUSIONS: We propose that the endothelial-lined trabecular structure of HCC everts, frondlike, via vascular structures within the tumor capsule into peritumoral vascular lumens without destruction of the endothelial coating. This may protect these HCC tumor projections from thrombus formation but may also act as a barrier to tumor extravasation, and this may be exploited from a therapeutic point of view.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15859635     DOI: 10.5858/2005-129-0639-VIAHBH

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Authors:  Colm Morrissey; Lawrence D True; Martine P Roudier; Ilsa M Coleman; Sarah Hawley; Peter S Nelson; Roger Coleman; Ya-Chun Wang; Eva Corey; Paul H Lange; Celestia S Higano; Robert L Vessella
Journal:  Clin Exp Metastasis       Date:  2007-10-31       Impact factor: 5.150

2.  The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.

Authors:  Liangliang Xu; Ming Zhang; Xiaobo Zheng; Pengsheng Yi; Chuan Lan; Mingqing Xu
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-10       Impact factor: 4.553

3.  Finally, a Minimally Invasive Option for Intrahepatic Inferior Vena Cava Invasion by Hepatocellular Carcinoma.

Authors:  Erik Soule; Jerry Matteo
Journal:  Gastrointest Tumors       Date:  2018-08-17

Review 4.  Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist.

Authors:  Alberto Quaglia
Journal:  J Hepatocell Carcinoma       Date:  2018-11-08

5.  A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation.

Authors:  Jiarui Yang; Shuguang Zhu; Juanjuan Yong; Long Xia; Xiangjun Qian; Jiawei Yang; Xueqiao Hu; Yuxuan Li; Chusi Wang; Wenguang Peng; Lei Zhang; Meihai Deng; Weidong Pan
Journal:  Front Oncol       Date:  2021-03-04       Impact factor: 6.244

6.  Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.

Authors:  Jacek M Kwiecien; Blessing I Bassey-Archibong; Wojciech Dabrowski; Lyndsay G Rayner; Alexandra R Lucas; Juliet M Daniel
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

7.  Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria.

Authors:  Yi-Fu Hou; Bo Li; Yong-Gang Wei; Jia-Yin Yang; Tian-Fu Wen; Ming-Qing Xu; L V-Nan Yan; Ke-Fei Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.